Efficacy of Vildagliptin Versus Metformin in Poly Cystic Ovary Syndrome: A Randomized Clinical Trial

Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Phase 2/Phase 3
SUMMARY

Polycystic ovary syndrome (PCOS) is an endocrine disorder that affects approximately 10-20% of women of reproductive age, Management strategies for PCOS include lifestyle modifications such as diet and physical activity that are the first-line approach to treatment; however, they are reported to be minimally effective in reducing weight or treating PCOS-related symptoms.Pharmacological options are also available; however, they are not explicitly approved for PCOS treatment as they have been primarily used to treat other conditions such as T2DM

Eligibility
Participation Requirements
Sex: Female
Minimum Age: 18
Maximum Age: 50
Healthy Volunteers: f
View:

• Women diagnosed with PCOS according to Rotterdam 2003 criteria National Institute of Health criteria.

Locations
Other Locations
Egypt
October 6 university hospital
RECRUITING
Giza
Contact Information
Primary
ahmed hussein, phD
ahmedhussein.med@o6u.edu.eg
01001749605
Backup
ahmed hussein
ahmedhussein.med@o6u.edu.eg
Time Frame
Start Date: 2023-11-25
Estimated Completion Date: 2026-02-01
Participants
Target number of participants: 60
Treatments
Active_comparator: Metformin
Active_comparator: Vildagliptin
Sponsors
Leads: October 6 University

This content was sourced from clinicaltrials.gov